Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Adjuvant Treatment in Premenopausal Breast Cancer

NCT06807749 ·Status: NOT_YET_RECRUITING

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

NCT00897299 ·Status: COMPLETED

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

NCT06646263 ·Status: ENROLLING_BY_INVITATION

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer

NCT04247035 ·Status: UNKNOWN

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

NCT01514565 ·Status: UNKNOWN

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 ·Status: UNKNOWN

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

NCT05733026 ·Status: UNKNOWN

Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments

NCT02662868 ·Status: COMPLETED

Triple-negative Breast Cancer: a New Perspective on Biomarkers

NCT03539965 ·Status: COMPLETED

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors

NCT01434420 ·Status: UNKNOWN ·Phase: NA

Study of Metabolites Markers in Adjuvant Breast Cancer

NCT03367208 ·Status: COMPLETED

Corellation of Mutations, TILs and Age in Breast Cancer

NCT04033965 ·Status: COMPLETED

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

NCT05923268 ·Status: COMPLETED ·Phase: NA

Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.

NCT07056205 ·Status: ENROLLING_BY_INVITATION

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

NCT04902937 ·Status: RECRUITING

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

NCT05528133 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

NCT04145947 ·Status: UNKNOWN

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA

NCT05939128 ·Status: ACTIVE_NOT_RECRUITING

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

NCT00080860 ·Status: COMPLETED ·Phase: NA

Genomic Signatures to Predict Treatment Response

NCT02032745 ·Status: COMPLETED

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420 ·Status: COMPLETED ·Phase: NA

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

NCT03947736 ·Status: UNKNOWN

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil

NCT05034393 ·Status: COMPLETED